Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor

Virology

Volumn 394, Issue 1, 2009, Pages 99-108

  Owen, David M ^a,b   Huang, Hua ^b   Ye, Jin ^b   Gale Jr , Michael ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

ApoB; ApoE; Entry; HCV; Hepatitis; LDL R; Lipoprotein; Receptor

Indexed keywords

25 HYDROXYCHOLESTEROL; APOLIPOPROTEIN B; APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; SMALL INTERFERING RNA; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

ARTICLE; FLOW CYTOMETRY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LIPOPROTEIN METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; RNA ANALYSIS; VIRION; VIRUS ENTRY;

APOLIPOPROTEINS E; GENE KNOCKDOWN TECHNIQUES; HEPACIVIRUS; HUMANS; PROTEIN BINDING; RECEPTORS, LDL; RECEPTORS, VIRUS; VIRUS ATTACHMENT; VIRUS INTERNALIZATION;

HEPATITIS C VIRUS;

EID: 70350124913     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.08.037     Document Type: Article

References (45)

1. Adams C.M., Reitz J., De Brabander J.K., Feramisco J.D., Li L., Brown M.S., and Goldstein J.L. Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and Insigs. J. Biol. Chem. 279 50 (2004) 52772-52780
2. Agnello V., Abel G., Elfahal M., Knight G.B., and Zhang Q.X. Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor. Proc. Natl. Acad. Sci. 96 22 (1999) 12766-12771
3. Andre P., Komurian-Pradel F., Deforges S., Perret M., Berland J.L., Sodoyer M., Pol S., Brechot C., Paranhos-Baccala G., and Lotteau V. Characterization of low-and very-low-density hepatitis C virus RNA-containing particles. J. Virol. 76 14 (2002) 6919-6928
4. Andreo U., Maillard P., Kalinina O., Walic M., Meurs E., Martinot M., Marcellin P., and Budkowska A. Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection. Cell. Microbiol. 9 10 (2007) 2445-2456
5. Bartosch B., Dubuisson J., and Cosset F.L. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J. Exp. Med. 197 5 (2003) 633-642
6. Bartosch B., Vitelli A., Granier C., Goujon C., Dubuisson J., Pascale S., Scarselli E., Cortese R., Nicosia A., and Cosset F.L. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J. Biol. Chem. 278 43 (2003) 41624-41630
7. Bays H.E., Tighe A.P., Sadovsky R., and Davidson M.H. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications. Expert Rev. Cardiovasc. Ther. 6 3 (2008) 391-409
8. Catanese M.T., Graziani R., von Hahn T., Moreau M., Huby T., Paonessa G., Santini C., Luzzago A., Rice C.M., Cortese R., Vitelli A., and Nicosia A. High-avidity monoclonal antibodies against the human scavenger class B type I receptor efficiently block hepatitis C virus infection in the presence of high-density lipoprotein. J. Virol. 81 15 (2007) 8063-8071
9. Chang K.S., Jiang J., Cai Z., and Luo G. Human apolipoprotein E Is required for infectivity and production of hepatitis C virus in cell culture. J. Virol. 81 24 (2007) 13783-13793
10. Chappell D.A., and Medh J.D. Receptor-mediated mechanisms of lipoprotein remnant catabolism. Prog. Lipid Res. 37 6 (1998) 393-422
11. Evans M.J., von Hahn T., Tscherne D.M., Syder A.J., Panis M., Wolk B., Hatziioannou T., McKeating J.A., Bieniasz P.D., and Rice C.M. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446 7137 (2007) 801-805
12. Flint M., Maidens C., Loomis-Price L.D., Shotton C., Dubuisson J., Monk P., Higginbottom A., Levy S., and McKeating J.A. Characterization of hepatitis c virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J. Virol. 73 8 (1999) 6235-6244
13. Foy E., Li K., Wang C., Sumpter R., Ikeda M., Lemon S.M., and Gale Jr. M. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300 (2003) 1145-1148
14. Gale Jr. M., Blakely C.M., Kwieciszewski B., Tan S.-L., Dossett M., Korth M.J., Polyak S.J., Gretch D.R., and Katze M.G. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol. Cell. Biol. 18 (1998) 5208-5218
15. Gastaminza P., Cheng G., Wieland S., Zhong J., Liao W., and Chisari F.V. Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion. J. Virol. 82 5 (2008) 2120-2129
16. Germi R., Crance J.-M., Garin D., Guimet J., Lortat-Jacob H., Ruigrok R.W.H., Zarski J.-P., and Drouet E. Cellular glycosaminoglycans and low density lipoprotein receptor are involved in hepatitis C virus adsorption. J. Med. Virol. 68 2 (2002) 206-215
17. Grove J., Nielsen S., Zhong J., Bassendine M.F., Drummer H.E., Balfe P., and McKeating J.A. Identification of a residue in hepatitis C virus E2 glycoprotein that determines scavenger receptor BI and CD81 receptor dependency and sensitivity to neutralizing antibodies. J. Virol. 82 24 (2008) 12020-12029
18. Hoofnagle J.H., and Seeff L.B. Peginterferon and ribavirin for chronic hepatitis C. N. Engl. J. Med. 355 23 (2006) 2444-2451
19. Huang H., Sun F., Owen D.M., Li W., Chen Y., Gale Jr. M., and Ye J. Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc. Natl. Acad. Sci. 104 14 (2007) 5848-5853
20. Hussain M.M., Rava P., Pan X., Dai K., Dougan S.K., Iqbal J., Lazare F., and Khatun I. Microsomal triglyceride transfer protein in plasma and cellular lipid metabolism. Curr. Opin. Lipidol. 19 3 (2008) 277-284
21. Kapadia S.B., Barth H., Baumert T., McKeating J.A., and Chisari F.V. Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I. J. Virol. 81 1 (2007) 374-383
22. Lauer G.M., and Walker B.D. Hepatitis C virus infection. N. Engl. J. Med. 345 1 (2001) 41-52
23. Lavillette D., Tarr A.W., Voisset C., Donot P., Bartosch B., Bain C., Patel A.H., Dubuisson J., Ball J.K., and Cosset F.L. Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus. Hepatology 41 2 (2005) 265-274
24. Loo Y.M., Owen D.M., li K., Erickson A.K., Johnson C.L., Fish P.M., Carney D.S., Wang T., Ishida H., Yoneyama M., Fujita T., Saito T., Lee W.M., Hagedorn C.H., Lau D.T., Weinman S.A., Lemon S.M., and Gale Jr. M. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc. Natl. Acad. Sci. U.S.A. 103 15 (2006) 6001-6006
25. Maillard P., Huby T., Andreo U., Moreau M., Chapman J., and Budkowska A. The interaction of natural hepatitis C virus with human scavenger receptor SR-BI/Cla1 is mediated by ApoB-containing lipoproteins. FASEB J. (2006) 05-4728fje
26. Martin C., Nielsen S.U., Ibrahim S., Bassendine M.F., and Toms G.L. Binding of liver derived, low density hepatitis C virus to human hepatoma cells. J. Med. Virol. 80 5 (2008) 816-823
27. Miyamoto H., Okamoto H., Sato K., Tanaka T., and Mishiro S. Extraordinarily low density of hepatitis C virus estimated by sucrose density gradient centrifugation and the polymerase chain reaction. J. Gen. Virol. 73 3 (1992) 715-718
28. Miyanari Y., Atsuzawa K., Usuda N., Watashi K., Hishiki T., Zayas M., Bartenschlager R., Wakita T., Hijikata M., and Shimotohno K. The lipid droplet is an important organelle for hepatitis C virus production. Nat. Cell. Biol. 9 9 (2007) 1089-1097
29. Molina S., Castet V., Fournier-Wirth C., Pichard-Garcia L., Avner R., Harats D., Roitelman J., Barbaras R., Graber P., Ghersa P., Smolarsky M., Funaro A., Malavasi F., Larrey D., Coste J., Fabre J.M., Sa-Cunha A., and Maurel P. The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus. J. Hepatol. 46 3 (2007) 411-419
30. Monazahian M., Böhme I., Bonk S., Koch A., Scholz C., Grethe S., and Thomssen R. Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J. Med. Virol. 57 3 (1999) 223-229
31. Morikawa K., Zhao Z., Date T., Miyamoto M., Murayama A., Akazawa D., Tanabe J., Sone S., and Wakita T. The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles. J. Med. Virol. 79 6 (2007) 714-723
32. Nahmias Y., Goldwasser J., Casali M., van Poll D., Wakita T., Chung R.T., and Yarmush M.L. Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin. Hepatology 45 5 (2008) 1437-1445
33. Pileri P., Uematsu Y., Campagnoli S., Galli G., Falugi F., Petracca R., Weiner A.J., Houghton M., Rosa D., Grandi G., and Abrignani S. Binding of hepatitis C virus to CD81. Science 282 5390 (1998) 938-941
34. Ploss A., Evans M.J., Gaysinskaya V.A., Panis M., You H., de Jong Y.P., and Rice C.M. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature (2009)
35. Prince A.M., Huima-Byron T., Parker T.S., and Levine D.M. Visualization of hepatitis C virions and putative defective interfering particles isolated from low-density lipoproteins. J. Viral Hepatitis 3 1 (1996) 11-17
36. Saito H., Dhanasekaran P., Nguyen D., Baldwin F., Weisgraber K.H., Wehrli S., Phillips M.C., and Lund-Katz S. Characterization of the heparin binding sites in human apolipoprotein E. J. Biol. Chem. 278 17 (2003) 14782-14787
37. Scarselli E., Ansuini H., Cerino R., Roccasecca R.M., Acali S., Filocamo G., Traboni C., Nicosia A., Cortese R., and Vitelli A. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO 21 19 (2002) 5017-5025
38. Thomssen R., Bonk S., Propfe C., Heermann K.H., K+|-chel H.G., and Uy A. Association of hepatitis C virus in human sera with +|-lipoprotein. Med. Microbiol. Immunol. 181 5 (1992) 293-300
39. Timpe J.M., Stamataki Z., Jennings A., Hu K., Farquhar M.J., Harris H.J., Schwarz A., Desombere I., Roels G.L., Balfe P., and McKeating J.A. Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies. Hepatology 47 1 (2008) 17-24
40. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Krausslich H.G., Mizokami M., Bartenschlager R., and Liang T.J. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11 7 (2005) 791-796
41. Wang C., Gale Jr. M., Keller B.C., Huang H., Brown M.S., Goldstein J.L., and Ye J. Identification of FBL2 as a geranylgeranylated cellular protein required for hepatitis C virus RNA replication 1. Mol. Cell 18 4 (2005) 425-434
42. Wunschmann S., Medh J.D., Klinzmann D., Schmidt W.N., and Stapleton J.T. Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor. J. Virol. 74 21 (2000) 10055-10062
43. Yao H., and Ye J. Long chain Acyl-CoA synthetase 3-mediated phosphatidylcholine synthesis is required for assembly of very low density lipoproteins in human hepatoma Huh7 cells. J. Biol. Chem. 283 2 (2008) 849-854
44. Ye J., Wang C., Sumpter Jr. R., Brown M.S., Goldstein J.L., and Gale Jr. M. Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation. Proc. Natl. Acad. Sci. U.S.A 100 26 (2003) 15865-15870
45. Zhang J., Randall G., Higginbottom A., Monk P., Rice C.M., and McKeating J.A. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J. Virol. 78 3 (2004) 1448-1455